Dhaliwal Harpreet S.'s Form 4 filing
Vaxcyte, Inc. (PCVX) · filed Sep 2, 2026
- Accession no.
- 0001886794-26-000010
- Filed
- Sep 2, 2026, 7:56 PM ET
- Trade date
- Aug 31-Sep 2, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dhaliwal Harpreet S.CIK 0001886794 | Officer (Chief Technical Ops Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | FTax withholdingDisposed | −361 | $60.74 | −$21,927.14 | 76,395 | Direct | |
| Sep 2, 2026 | Common Stock | FTax withholdingDisposed | −659 | $61.58 | −$40,581.22 | 75,736 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.